Data S1. Human PGBD5 DNA transposase promotes site-specific oncogenic mutations in rhabdoid tumors

Published December 6, 2016 | Version v1

Dataset Open

1. Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA
2. Cancer Biology & Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA
3. Program in Bioinformatics and Integrative Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA.
4. Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS)
5. Department of Biochemistry, The Gurdon Institute, University of Cambridge, Cambridge, United Kingdom
6. Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA
7. Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
8. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
9. New York Genome Center, New York, NY, USA
10. Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, NY
11. Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA
12. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
13. Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN, USA
14. Department of Pathology, Boston Children's Hospital, Boston, MA, USA
15. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Supplementary data S1 for Henssen et al. "

Human PGBD5 DNA transposase promotes site-specific oncogenic mutations in rhabdoid tumors"

Files

Name	Size	Download all
Henssen_etal_SupplementaryData_S1.zip md5:a1cd175097710689e99a2810aa32afd4	23.9 MB	Preview Download